Pamela Esposito - 20 Jul 2021 Form 4 Insider Report for Replimune Group, Inc. (REPL)

Role: Chief Business Officer
Signature: /s/ Jean Franchi, attorney-in-fact
Issuer symbol: REPL
Transactions as of: 20 Jul 2021
Net transactions value: -$559,001
Form type: 4
Filing time: 22 Jul 2021, 21:01:05 UTC
Previous filing: 19 Jul 2021
Next filing: 06 Aug 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	REPL	Common Stock	Options Exercise	$4,911	+4,862	+2.3%	$1.01^*	215,021	20 Jul 2021	Direct
transaction	REPL	Common Stock	Sale	$160,689	-4,862	-2.3%	$33.05	210,159	20 Jul 2021	Direct	F1
transaction	REPL	Common Stock	Options Exercise	$12,663	+12,538	+6%	$1.01^*	222,697	21 Jul 2021	Direct
transaction	REPL	Common Stock	Sale	$415,885	-12,538	-5.6%	$33.17	210,159	21 Jul 2021	Direct	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	REPL	Employee Stock Option (right to buy)	Options Exercise	$0	-4,862	-7.1%	$0.000000	63,741	20 Jul 2021	Common Stock	4,862	$1.01	Direct	F3
transaction	REPL	Employee Stock Option (right to buy)	Options Exercise	$0	-12,538	-20%	$0.000000	51,203	21 Jul 2021	Common Stock	12,538	$1.01	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The sales reported on this Form 4 were made by the reporting person pursuant to a trading plan adopted on December 14, 2020 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended.
F2	Following the sales reported on this Form 4, the reporting person continues to beneficially own 210,159 shares of the Issuer's common stock. The reporting person also holds options to acquire an aggregate of 488,102 shares of the Issuer's common stock, 324,649 of which are exercisable as of the date hereof. Due to scrivener's error, footnote 2 of the Form 4 filed on behalf of the reporting person on July 19, 2021 inadvertently overstated the number of options held by the Reporting Person following the transaction reported therein. The amounts stated in this footnote 2 set forth the correct number of options held by the Reporting Person following the transaction reported herein.
F3	The reporting person was granted an option to purchase 149,203 shares of the Issuer's common stock on November 1, 2015. All of the shares underlying such stock option have vested and are exercisable as of the date hereof.